HYBRID EVENT: Join us in person in Rome, Italy or attend virtually from anywhere.

13th Edition of International Conference on

Neurology, Brain Health & Neurological Disorders

June 24-26, 2027 | Rome, Italy

Lewy Body Dementia

Lewy Body Dementia

Lewy body dementia (LBD) is a progressive, neurodegenerative brain disorder caused by the accumulation of proteins called alpha-synuclein in certain areas of the brain, known as Lewy bodies. It is typically characterized by a gradual decline in cognitive function and gradual deterioration of physical and behavioral abilities. Common symptoms include difficulty with reasoning, memory and language, significant changes in behavior, difficulty with energy and sleep, and impaired motor coordination. The most common form of LBD is dementia with Lewy bodies (DLB), also known as Lewy body dementia. DLB is the most common form of dementia after Alzheimer’s disease and typically affects adults between the age of 55 and 80. Its prevalence is estimated at 2–3 % amongst all dementias with most cases diagnosed amongst those aged 70 and over. LBD is the result of a protein accumulation in certain regions of the brain including the cortex, hippocampus, locus coeruleus, basal ganglia, and other nuclei structures. The protein buildup causes cell death and central nervous system dysfunction over time, leading to cognitive decline. Lewy bodies themselves, along with other signs of neurofibrillary pathology, are observed in the autopsy of LBD patients. Cognitive decline in Lewy body dementia is further characterized by fluctuations in attention, executive functioning, and the ability to concentrate. Patients may also be more prone to experiencing visual and auditory hallucinations, especially as the disease progresses. Additionally, the motor features of the disease may include bradykinesia, gait disturbances, and postural instability. Early diagnosis of Lewy body dementia can be difficult due to its symptoms overlapping with those of other dementias such as Alzheimer’s and Parkinson’s disease. In fact, LBD may be misdiagnosed as one of these other conditions up to 70% of the time. Therefore, it is important for health professionals to be familiar with the signs and symptoms of LBD during the diagnostic process. Currently, there is no cure for Lewy body dementia, but research continues. Treatment generally focuses on treating some of the more pronounced symptoms and providing supportive care; this may include medications to reduce hallucinations, treat anxiety or depression, improve sleep, or improve motor coordination. As with any chronic condition, it is important to partner with a doctor to determine the best course of treatment. 

Committee Members
Speaker at  Neurology, Brain Health & Neurological Disorders 2027 - W S El Masri

W S El Masri

Keele University, United Kingdom
Speaker at  Neurology, Brain Health & Neurological Disorders 2027 - Sid O Bryant

Sid O Bryant

Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States
Speaker at  Neurology, Brain Health & Neurological Disorders 2027 - Bernd Blobel

Bernd Blobel

University of Regensburg, Germany
Neurology 2027 Speakers
Speaker at  Neurology, Brain Health & Neurological Disorders 2027 - Luiz Moutinho

Luiz Moutinho

University of Suffolk, United Kingdom
Speaker at  Neurology, Brain Health & Neurological Disorders 2027 - Bernd Blobel

Bernd Blobel

University of Regensburg, Germany
Speaker at  Neurology, Brain Health & Neurological Disorders 2027 - Salvador Ventura

Salvador Ventura

Autonomous University of Barcelona, Spain
Speaker at  Neurology, Brain Health & Neurological Disorders 2027 - Zhenhuan Liu

Zhenhuan Liu

Guangzhou University of Chinese Medicine, China

Submit your abstract Today

Watsapp